Recurrences of uterine fibroids. The modern view on the problems of diagnosis, treatment, and prognosis

1. Duhan N. Current and emerging treatments for uterine myoma – an update. Int. J. Women’s Health. 2011; 3: 231-41. http:// dx.doi.org/10.2147/IJWH.S15710
2. Donnez J., Tatarchuk T.F., Bouchard P., Puscasiu L., Zakharenko N.F., Ivanova T. et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N. Engl. J. Med. 2012; 366(5): 409-20. http:// dx.doi.org/1056/NEJMoa1103182
3. Bourdel N., Bonnefoy C., Jardon K., Da Ines D., Tognazza E., Rabischong B. et al. Myomectomie hystéroscopique: récidive et enquête de satisfaction à court et long terme. J. Gynecol. Obstet. Biol. Reprod. (Paris). 2011; 40(2): 116-22. http:// dx.doi.org/10.1016/j.jgyn.2011.01.003
4. Zimmermann A., Bernuit D., Gerlinger C., Schaefers M., Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. Womens Health. 2012; 12: 6.
5. Тихомиров А.Л. Миома матки. Патогенетическое обоснование органосохраняющего лечения. Монография. М.; 2013. [Tikhomirov A.L. Uterine fibroids. Pathogenetic rationale for organ-sparing treatment. Monograph. M .; 2013. (in Russian)].
6. Адамян Л.В., Серов В.Н., Сухих Г.Т., Филиппов О.С., ред. Клинические рекомендации. Акушерство и гинекология Проблемы репродукции. 2015; 21(6, Спецвыпуск). Adamyan L.V., Serov V.N., Sukhih G.T., Filippov O.S. Clinical recommendations. Obstetrics and gynecology (special issue). Problemy reprodukcii. 2015, tom 21, №6, S.321. (in Russian)].
7. Laganà A.S., Vergara D., Favilli A., La Rosa V.L., Tinelli A., Gerli S. et al. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch. Gynecol. Obstet. 2017; 296(5): 855-67. http:// dx.doi.org/10.1007/s00404-017-4515-5
8. Sparic R., Mirkovic L., Malvasi A., Tinelli A. Epidemiology of uterine myomas: a review. Int. J. Fertil. Steril. 2016; 9(4): 424-35.
9. Ciavattini A., Di Giuseppe J., Stortoni P., Montik N., Giannubilo S.R., Litta P. et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet. Gynecol. Int. 2013; 2013; 173184. http://dx.doi.org/10.1155/2013/173184
10. Mäkinen N., Mehine M., Tolvanen J., Kaasinen E., Li Y., Lehtonen H.J. et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011; 334(6053): 252-5.
11. Chen Y.J., Li Y.T., Huang B.S., Yen M.S., Sheu B.C., Chow S.N. et al. Medical treatment for heavy menstrual bleeding. Taiwan. J. Obstet. Gynecol. 2015; 54: 483-8.
12. Адамян Л.В. Состояние репродуктивной системы больных доброкачественными опухолями внутренних половых органов и принципы ее восстановления после хирургического лечения: дисс. … д-ра мед. наук. М.; 1985. [L.V.Adamyan. The state of the reproductive system of patients with benign tumors of the internal genital organs and the principles of its recovery after surgical treatment: Diss. ... Dr. med sciences. M .; 1985. (in Russian)].
13. Donnez J., Donnez O., Dolmans M. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertil. Steril. 2014; 102(3): 640-8.
14. Поротикова И.Е., Адамян Л.В., Демура Т.А., Гаврилова Т.Ю., Доброхотова Ю.Э. Лейомиома тела матки у женщин репродуктивного возраста после ранее перенесенной эмболизации маточных артерий, фокусированной ультразвуковой абляции под контролем МРТ и миомэктомии: молекулярные, морфологические и клинические особенности. Проблемы репродукции. 2016; 22(2): 44-50. [I.E. Porotikova, L.V. Adamyan, T.A. Demura, T.Yu. Gavrilova, Yu.E. Dobrokhotova. Uterine leiomyoma in women of reproductive age after previously performed uterine artery embolization, focused ultrasound ablation controlled by MRI and myomectomy: molecular, morphological and clinical features. Problemy reprodukcii, 2, 2016. 44-50. (in Russian)]. http:// dx.doi.org/10.17116/repro201622244-50
15. Вихляева Е.М., Паллади Г.А. Патогенез, клиника и лечение миомы матки. Кишинев: Штиинца; 1982. [Vihlyaeva E.M., Palladi G.A. Pathogenesis, clinic and treatment of uterine fibroids. Kishinev: Shtiintsa; 1982. (in Russian)].
16. Поротикова И.Е., Адамян Л.В., Гаврилова Т.Ю., Демура Т.А., Козаченко И.Ф., Доброхотова Ю.Э., Асатурова А.В. Особенности хирургического лечения больных миомой матки после ранее перенесенной неэффективной эмболизации маточных артерий и ФУЗ-МРТ абляции. Проблемы репродукции. 2016; 22(3): 45-52. http:// dx.doi.org/10.17116/repro201622345-52. [I.E. Porotikova, L.V. Adamyan, T.YU. Gavrilova, T.A. Demura, I.F. Kozachenko, YU.E. Dobrokhotova, A.V. Asaturova. Surgical treatment of uterine myoma after ineffective UAE and MRgFUS ablation. (in Russian)].
17. Doridot V., Dubuisson J.B., Chapron C., Fauconnier A., Babaki-Fard K. Recurrence of leiomyomata after laparoscopic myomectomy. J. Am. Assoc. Gynecol. Laparosc. 2001; 8(4): 495-500.
18. Караваев Ю.Е., Аскольская С.И., Коган Е.А. Прогностические критерии рецидива лейомиомы матки после реконструктивно-пластических операций. Акушерство и гинекология. 2013; 5: 54-7. [Yu.E.Karavaev, S.I. Askol'skaya, E.A.Kogan. Prognostic criteria for recurrence of uterine leiomyoma after reconstructive plastic surgery. Obstetrics and gynecology. 2013; 5: 54-7. (in Russian)].
19. Коган Е.А., Игнатова В.Е., Унанян А.Л., Сидорова И.С. Соотношение процессов пролиферации и апоптоза в разных гистологических типах лейомиомы матки. Архив патологии. 2005; 67(4): 32-6. [Kogan E.A., Ignatova V.E., Unanyan A.L. Proliferation and apoptosis in different histological types of uterine leiomyoma. Arhiv patologii. 2005, tom 67, № 40, S. 32-36. (in Russian)].
20. Li M.H., Leng J.H., Shi J.H., Jia S.Z,. Lang J.H. Comparison of postoperative residue, recurrence and pregnancy outcome between laparoscopic and transabdominal myomectomy. Zhonghua Fu Chan Ke Za Zhi. 2011; 46(9): 669-73.
21. Hirschelmann A., De Wilde R.L. Plastic and reconstructive uterus operations by minimally invasive surgery? A review on myomectomy. GMS Interdiscip. Plast. Reconstr. Surg. DGPW. 2012; 1: Doc09. http:// dx.doi.org/10.3205/iprs000009.
22. Wen K.C., Sung P.L., Chang W.H., Horng H.C., Chen Y.J., Lee WL., Wang P.H. A case-control study to compare the outcome of women treated by two minimally invasive procedures-ultraminilaparotomy myomectomy and laparoscopic myomectomy. Taiwan. J. Obstet. Gynecol. 2018; 57(2): 264-9. http://dx.doi.org/10.1016/j.tjog.2018.02.016
23. Jacobson G.F., Shaber R.E., Armstrong M.A., Hung Y.Y. Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma. Am. J. Obstet. Gynecol. 2007; 196(6): 601. e1-5; discussion 601. e5-6. http:// dx.doi.org/10.1016/j.ajong.2007.03.009
24. Nishiyama S., Saito M., Sato K., Kurishita M., Itasaka T., Shioda K. High recurrence rate of uterine fibroids on transvaginal ultrasound after abdominal myomectomy in Japanese women. Gynecol. Obstet. Invest. 2006; 61(3): 155-9. http:// dx.doi.org/10.1159/000090628
25. Yoo E.H., Lee P.I., Huh C.Y., Kim D.H., Lee B.S., Lee J.K., Kim D. Predictors of leiomyoma recurrence after laparoscopic myomectomy. J. Minim. Invasive Gynecol. 2007; 14(6): 690-7.
26. Rothmund R., Kurth R.R., Lukasinski N.M., Huebner M., Hartkopf A., Wallwiener M. et al. Clinical and pathological characteristics, pathological reevaluation and recurrence patterns of cellular leiomyomas: a retrospective study in 76 patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 171(2): 358-61. http:// dx.doi.org/10.1016/j.ejogrb.2013.10.004
27. Shin D.G., Yoo H.J., Lee Y.A., Kwon I.S., Lee K.H. Recurrence factors and reproductive outcomes of laparoscopic myomectomy and minilaparotomic myomectomy for uterine leiomyomas. Obstet. Gynecol. Sci. 2017; 60(2): 193-9. http:// dx.doi.org/10.5468/ogs.2017.60.2.193
28. Вихляева Е.М., Ходжаева З.С., Фанченко Н.Д. Клинико-генеалогическое изучение наследственной предрасположенности к заболеванию миомой матки. Акушерство и гинекология. 1998; 2: 27-31. 1998. [Vihlyaeva E.M., Hodzhaeva Z.S., Fanchenko N.D. Clinical and genealogical study of hereditary susceptibility to uterine myoma disease. Obstetrics and gynecology. 1998; 2: 27-31. 1998. (in Russian)].
29. Адамян Л.В., Спицын В.А., Андреева Е.Н. Генетические аспекты гинекологических заболеваний. М.: Медицина; 1998. [L.V.Adamyan, V.A.Spicyn, E.N.Andreeva. Genetic aspects of gynecological diseases. M .: Medicine; 1998. (in Russian)].
30. Celik et al., 2004, Podo F., Sardanelli F., Iorio E., Canese R., Carpinelli G., Fausto A. et al. Abnormal choline phospholipid metabolism in breast and ovary cancer: Molecular bases for noninvasive imaging approaches. Curr. Med. Imaging. Rev. 2007; 3: 123-37.
31. Адамян Л.В., Караваев Ю.Е., Аскольская С.И. Состояние репродуктивной функции женщин после операции миомэктомии, выполненной разными доступами. В кн.: Материалы XXIV Международного конгресса с курсом эндоскопии «Новые технологии в диагностике и лечении гинекологических заболеваний». М.; 2011: 66-7. [L.V. Adamyan, J.E. Karavaev, S.I. Askol'skaja. The state of reproductive function of women after surgery myomectomy performed by different approaches. In: Materials of the XXIV International Congress with the course of endoscopy «New technologies in the diagnosis and treatment of gynecological diseases.» M .; 2011: 66-7. (in Russian)].
32. Лисица А.В., Пономаренко Е.А., Лохов П.Г. Постгеномная медицина: альтернатива биомаркерам. Вестник Российской Академии медицинских наук. 2016; 3: 255-60. [A.V. Lisica, E.A. Ponomarenko, P.G. Lohov. Post-genomic medicine: an alternative to biomarkers. Vestnik Rossijskoj Akademii medicinskih nauk. 2016. №3. – C. 255-260. (in Russian)].
33. Писарев Д.И., Новиков О.О., Фадеева Д.А., Жилякова Е.Т., Казакова В.С., Писарева Н.А. Масс-спектрометрия: история и перспективы использования. Молодой ученый. 2012; 10: 99-104. [Pisarev D.I., Novikov O.O., Fadeeva D.A., Zhilyakova E.T., Kazakova V.S., Pisareva N.A. Mass spectrometry: history and prospects of use. Young scientist. 2012; 10: 99-104. (in Russian)].
34. Ding X., Wang L., Ren Y., Zheng W. Differences in mitochondrial proteins in the eutopic endometrium of patients with adenomyosis and endometriosis identified using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. J. Int. Med. Res. 2010; 38(3): 987-93.
35. De Petris L., Pernemalm M., Elmberger G., Bergman P., Orre L., Lewensohn R., Lehtiö J. A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants. Proteome Sci. 2010; 8: 9.
36. Pourfarzam M., Zadhoush F. Newborn Screening for inherited metabolic disorders; news and views. J. Res. Med. Sci. 2013; 18(9): 801-8.
37. Mischak H. Urine proteomics as a liquid kidney biopsy: no more kidney punctures. Nephrol. Dial. Transplant. 2015; 30(4): 532-7.
38. Buhimschi I.A., Nayeri U.A., Zhao G., Shook L.L., Pensalfini A., Funai E.F. et al. Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci. Transl. Med. 2014; 6(245): 245ra92.
39. Meng Q.H. Mass spectrometry applications in clinical diagnostics. J. Clin. Exp. Pathol. 2013; 1(Suppl. 6): e001.
40. Wang H., Manicke N.E., Yang Q., Zheng L., Shi R., Cooks R.G., Ouyang Z. Direct analysis of biological tissue by paper spray mass spectrometry. Anal. Chem. 2011; 83(4): 1197-201.
41. Pietrowska M., Marczak L., Polanska J., Behrendt K., Nowicka E., Walaszczyk A. et al. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer. J. Transl. Med. 2009; 7: 60.
42. Борисова А.В., Чаговец В.В., Козаченко А.В., Стародубцева Н.Л., Кононихин А.С., Салимова Д.Ф., Коган Е.А., Адамян Л.В., Франкевич В.Е., Сухих Г.Т.Сравнительный анализ липидного состава перитонеальной жидкости и плазмы крови у пациенток с наружным генитальным эндометриозом и миомой матки. Акушерство и гинекология. 2017; 6: 74-82. [A.V. Borisova, V.V. Chagovets, A.V. Kozachenko, N.L. Starodubseva, A.S. Kononikhin, D.F.Salimova, E.A. Kogan, L.V. Adamyan, V.E. Frankevich, G.T. Sukhikh. Comparative analysis of the lipid composition of composition of peritoneal fluid and blood plasma in patients with external genital endometriosis and uterine myoma. Akusherstvo i ginekologiya. 2017. № 6. (in Russian)]. http:// dx.doi.org/10.18565/aig.2017.6.74-82
43. Balog J., Szaniszlo T., Schaefer K.C., Denes J., Lopata A., Godorhazy L. et al. Identification of biological tissues by rapid evaporative ionization mass spectrometry. Anal Chem. 2010; 82(17): 7343-50.
44. Zhang W., Wang X., Xia Y., Ouyang Z. Ambient ionization and miniature mass spectrometry systems for disease diagnosis and therapeutic monitoring. Theranostics. 2017; 7: 2968-81.
45. Cooks R.G., Manicke N.E., Dill A.L., Ifa L.S., Costa A.B., Wang H. et al. New ionization methods and miniature mass spectrometers for biomedicine: DESI imaging for cancer diagnostics and paper spray ionization for therapeutic drug monitoring. Faraday Discuss. 2011; 149: 247-67.
46. Guenther S., Muirhead L.J., Speller A.V., Golf O., Strittmatter N., Ramakrishnan R. et al. Spatially resolved metabolic phenotyping of breast cancer by desorption electrospray ionization mass spectrometry. Cancer Res. 2015; 75(9): 1828-37.
47. Ashizawa K., Yoshimura K., Johno H., Inoue T., Katoh R., Funayama S. et al. Construction of mass spectra database and diagnosis algorithm for head and neck squamous cell carcinoma. Oral Oncol. 2017; 75: 111-9. http:// dx.doi.org/10.1016/j.oraloncology.2017.11.008
48. Kerian K.S., Jarmusch A.K., Cooks R.G. Touch spray mass spectrometry for in situ analysis of complex samples. Analyst. 2014; 139(11): 2714-20.
49. Kerian K.S., Jarmusch A.K., Pirro V., Koch M.O., Masterson T.A., Cheng L., Cooks R.G. Differentiation of prostate cancer from normal tissue in radical prostatectomy specimens by desorption electrospray ionization and touch spray ionization mass spectrometry. Analyst. 2015; 140(4): 1090-8.
50. St John E.R., Balog J., McKenzie J.S., Rossi M., Covington A., Muirhead L. et al. Rapid evaporative ionisation mass spectrometry of electrosurgical vapours for the identification of breast pathology: towards an intelligent knife for breast cancer surgery. Breast Cancer Res. 2017; 19(1): 59. http:// dx.doi.org/10.1186/s13058-017-0845-2
51. Jamaluddin M.F.B., Nagendra P.B., Nahar P., Oldmeadow C., Tanwar P.S. Proteomic analysis identifies tenascin-C expression is upregulated in uterine fibroids. Reprod. Sci. 2018; 26(4): 476-86. http:// dx.doi.org/10.1177/1933719118773420
52. Heinonen H.R., Mehine M., Mäkinen N., Pasanen A., Pitkänen E., Karhu A. et al. Global metabolomic profiling of uterine Leiomyomas. Br. J. Cancer. 2017; 117(12): 1855-64. http:// dx.doi.org/10.1038/bjc.2017.361
53. Heinonen H.R., Pasanen A., Heikinheimo O., Tanskanen T., Palin K., Tolvanen J. et al. Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas. Sci. Rep. 2017; 7: 1015.

Received 15.06.2018

Accepted 22.06.2018